Is Pregabalin 150 mg a Narcotic or Controlled Substance?

Pregabalin 150 mg is not a narcotic. It belongs to a completely different drug class called anticonvulsants (sometimes referred to as gabapentinoids), and it works through a mechanism that has nothing in common with narcotics like oxycodone, morphine, or fentanyl. That said, pregabalin is a controlled substance in the United States, which is likely why the question comes up.

How Pregabalin Differs From Narcotics

Narcotics (opioids) work by binding to opioid receptors in the brain and spinal cord, which blocks pain signals and produces sedation and euphoria. Pregabalin does none of this. When tested against 38 different receptors and ion channels in the body, pregabalin did not interact with any of them, including opioid receptors.

Instead, pregabalin attaches to a specific part of calcium channels on nerve cells. By doing so, it reduces the release of several chemical messengers involved in pain signaling. Think of it as turning down the volume on overactive nerves rather than numbing the pain receptor itself. This is why pregabalin is prescribed for nerve pain conditions like diabetic neuropathy, post-shingles pain, fibromyalgia, and spinal cord injury pain, as well as partial-onset seizures.

Why It’s Still a Controlled Substance

In 2005, the DEA placed pregabalin into Schedule V of the Controlled Substances Act. Schedule V is the lowest level of control, reserved for drugs with limited but real potential for misuse. For comparison, narcotics like oxycodone sit in Schedule II, which reflects a much higher abuse risk. Over-the-counter cough medicines containing small amounts of codeine are also Schedule V.

The scheduling exists because pregabalin can produce feelings of euphoria in some people, particularly at high doses. Case reports describe individuals who escalated their use well beyond prescribed amounts, developed tolerance, and experienced withdrawal symptoms including sweating, tremor, restlessness, high blood pressure, and intense cravings. One published case documented a patient who took 20 capsules at once after attempting to quit. These patterns resemble substance dependence, even though the drug is not an opioid.

In the UK, pregabalin was reclassified as a Class C controlled substance in 2019 due to rising misuse, placing it under tighter restrictions than in the U.S.

What 150 mg Actually Means as a Dose

A 150 mg capsule is a common starting or moderate dose, depending on the condition being treated. For post-shingles nerve pain, a typical starting dose is 75 to 150 mg taken twice daily. For seizures, the starting point is often 150 mg per day split into two or three doses. Fibromyalgia treatment usually begins at 75 mg twice daily, with a maximum of 450 mg per day. Diabetic nerve pain starts lower, at 50 mg three times daily, with a ceiling of 300 mg per day.

So if you’ve been prescribed a single 150 mg capsule, you’re at the lower end of the dosing range for most conditions. Maximum daily doses can reach 600 mg depending on the diagnosis.

Respiratory Risks When Combined With Opioids

Even though pregabalin is not a narcotic, mixing it with one can be dangerous. The FDA issued a safety warning that serious breathing problems may occur when pregabalin is used alongside opioid pain medicines, benzodiazepines, or other drugs that depress the central nervous system. People with lung conditions like COPD and older adults face the highest risk.

The FDA has also required pregabalin’s manufacturer to conduct clinical trials specifically evaluating the abuse potential of pregabalin when combined with opioids, because co-use of these drugs is increasing. If you take both an opioid and pregabalin, watch for unusual drowsiness, slowed breathing, or confusion, especially when starting treatment or increasing your dose.

What to Expect When Taking It

Pregabalin is absorbed quickly and tends to work faster than many other nerve pain or anxiety medications. In clinical trials using 150 mg per day for anxiety, noticeable effects appeared within the first week. Pain relief timelines vary by condition, but most people can gauge whether the drug is helping within the first two to four weeks as the dose is adjusted.

Common side effects include dizziness, drowsiness, dry mouth, and weight gain. Because pregabalin can cause physical dependence even at prescribed doses, stopping abruptly is not recommended. Tapering gradually over at least a week helps avoid withdrawal symptoms like headaches, sleep problems, nausea, and anxiety.